Gene Page: ADRB2
Summary ?
GeneID | 154 |
Symbol | ADRB2 |
Synonyms | ADRB2R|ADRBR|B2AR|BAR|BETA2AR |
Description | adrenoceptor beta 2 |
Reference | MIM:109690|HGNC:HGNC:286|HPRD:00187| |
Gene type | protein-coding |
Map location | 5q31-q32 |
Pascal p-value | 0.415 |
Sherlock p-value | 0.076 |
Fetal beta | -0.561 |
eGene | Myers' cis & trans |
Support | GPCR SIGNALLING |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS | |
PMID:cooccur | High-throughput literature-search | Systematic search in PubMed for genes co-occurring with SCZ keywords. A total of 3027 genes were included. | |
GSMA_I | Genome scan meta-analysis | Psr: 0.0032 | |
GSMA_IIE | Genome scan meta-analysis (European-ancestry samples) | Psr: 0.01718 | |
GSMA_IIA | Genome scan meta-analysis (All samples) | Psr: 0.00459 | |
Literature | High-throughput literature-search | Co-occurance with Schizophrenia keywords: schizophrenia,schizophrenic,schizophrenics,schizophrenias | Click to show details |
GO_Annotation | Mapping neuro-related keywords to Gene Ontology annotations | Hits with neuro-related keywords: 2 | |
Network | Shortest path distance of core genes in the Human protein-protein interaction network | Contribution to shortest path in PPI network: 4.6166 |
Section I. Genetics and epigenetics annotation
eQTL annotation
SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
rs10994209 | chr10 | 61877705 | ADRB2 | 154 | 0.15 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression during devlopment (BrainCloud)
Footnote:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
Top 10 positively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
MAP2 | 0.89 | 0.92 |
DCLK1 | 0.88 | 0.91 |
KIF3B | 0.87 | 0.89 |
MAPRE2 | 0.86 | 0.89 |
ABI2 | 0.86 | 0.90 |
GNAQ | 0.86 | 0.90 |
DLG3 | 0.86 | 0.89 |
CAMSAP1L1 | 0.86 | 0.90 |
PAFAH1B1 | 0.86 | 0.89 |
EDEM3 | 0.85 | 0.88 |
Top 10 negatively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
FXYD1 | -0.64 | -0.69 |
HSD17B14 | -0.63 | -0.68 |
HIGD1B | -0.63 | -0.71 |
METRN | -0.63 | -0.72 |
TLCD1 | -0.63 | -0.68 |
ENHO | -0.63 | -0.75 |
ACSF2 | -0.62 | -0.69 |
RAB34 | -0.62 | -0.69 |
MT-CO2 | -0.62 | -0.68 |
AF347015.31 | -0.62 | -0.67 |
Section III. Gene Ontology annotation
Molecular function | GO term | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
GO:0051380 | norepinephrine binding | IDA | Neurotransmitter (GO term level: 4) | 15123695 |
GO:0004872 | receptor activity | IEA | - | |
GO:0004941 | beta2-adrenergic receptor activity | IDA | 15123695 | |
GO:0005515 | protein binding | IPI | 9560162 | |
GO:0042803 | protein homodimerization activity | IDA | 15123695 | |
Biological process | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0000187 | activation of MAPK activity | TAS | 9924018 | |
GO:0002024 | diet induced thermogenesis | IEA | - | |
GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure | IEA | - | |
GO:0002028 | regulation of sodium ion transport | IEA | - | |
GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin | IDA | 15123695 | |
GO:0007190 | activation of adenylate cyclase activity | IDA | 15123695 | |
GO:0007189 | G-protein signaling, adenylate cyclase activating pathway | IEA | - | |
GO:0007186 | G-protein coupled receptor protein signaling pathway | TAS | 9924018 | |
GO:0007243 | protein kinase cascade | TAS | 10734107 | |
GO:0008333 | endosome to lysosome transport | TAS | 9507004 | |
GO:0009409 | response to cold | IEA | - | |
GO:0006898 | receptor-mediated endocytosis | IDA | 15123695 | |
GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity | TAS | 10734107 | |
GO:0040015 | negative regulation of multicellular organism growth | IEA | - | |
GO:0030501 | positive regulation of bone mineralization | IEA | - | |
GO:0050873 | brown fat cell differentiation | IEA | - | |
GO:0031649 | heat generation | IEA | - | |
GO:0043410 | positive regulation of MAPKKK cascade | IDA | 15123695 | |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | IEA | - | |
GO:0045986 | negative regulation of smooth muscle contraction | IEA | - | |
GO:0045453 | bone resorption | IEA | - | |
Cellular component | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0043235 | receptor complex | IDA | Neurotransmitter (GO term level: 4) | 15123695 |
GO:0005624 | membrane fraction | IEA | - | |
GO:0005634 | nucleus | IEA | - | |
GO:0005764 | lysosome | TAS | 9507004 | |
GO:0005768 | endosome | TAS | 10734107 | |
GO:0005886 | plasma membrane | IDA | 9235896 | |
GO:0005887 | integral to plasma membrane | TAS | 9228019 | |
GO:0016324 | apical plasma membrane | IEA | - |
Section IV. Protein-protein interaction annotation
Interactors | Aliases B | Official full name B | Experimental | Source | PubMed ID |
---|---|---|---|---|---|
ADRB2 | ADRB2R | ADRBR | B2AR | BAR | BETA2AR | adrenergic, beta-2-, receptor, surface | FRET | BioGRID | 11278447 |
ADRBK1 | BARK1 | BETA-ARK1 | FLJ16718 | GRK2 | adrenergic, beta, receptor kinase 1 | Affinity Capture-Western | BioGRID | 11309381 |
AKAP12 | AKAP250 | DKFZp686M0430 | DKFZp686O0331 | FLJ20945 | FLJ97621 | A kinase (PRKA) anchor protein 12 | - | HPRD,BioGRID | 9880537 |11309381|11309381 |
AKAP5 | AKAP75 | AKAP79 | H21 | A kinase (PRKA) anchor protein 5 | - | HPRD | 10753752 |
ARR3 | ARRX | arrestin 3, retinal (X-arrestin) | - | HPRD | 11877451 |
EIF2B1 | EIF-2B | EIF-2Balpha | EIF2B | EIF2BA | MGC117409 | MGC125868 | MGC125869 | eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa | eIF2B-alpha interacts with the cytoplasmic, carboxy-terminus of the beta-2 adrenergic receptor. | BIND | 9235896 |
EIF2B1 | EIF-2B | EIF-2Balpha | EIF2B | EIF2BA | MGC117409 | MGC125868 | MGC125869 | eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa | - | HPRD,BioGRID | 9235896 |
GNA11 | GNA-11 | guanine nucleotide binding protein (G protein), alpha 11 (Gq class) | - | HPRD | 7797501 |
GNA14 | - | guanine nucleotide binding protein (G protein), alpha 14 | - | HPRD | 7797501 |
GNA15 | GNA16 | guanine nucleotide binding protein (G protein), alpha 15 (Gq class) | - | HPRD | 7608160 |7797501 |
GRB2 | ASH | EGFRBP-GRB2 | Grb3-3 | MST084 | MSTP084 | growth factor receptor-bound protein 2 | - | HPRD,BioGRID | 9830057 |
GRK6 | FLJ32135 | GPRK6 | G protein-coupled receptor kinase 6 | - | HPRD,BioGRID | 9819198 |
KCNJ3 | GIRK1 | KGA | KIR3.1 | potassium inwardly-rectifying channel, subfamily J, member 3 | Affinity Capture-Western | BioGRID | 12297500 |
KCNJ5 | CIR | GIRK4 | KATP1 | KIR3.4 | potassium inwardly-rectifying channel, subfamily J, member 5 | Affinity Capture-Western | BioGRID | 12297500 |
KCNJ6 | BIR1 | GIRK2 | KATP2 | KCNJ7 | KIR3.2 | MGC126596 | hiGIRK2 | potassium inwardly-rectifying channel, subfamily J, member 6 | - | HPRD | 12297500 |
KCNJ9 | GIRK3 | KIR3.3 | potassium inwardly-rectifying channel, subfamily J, member 9 | - | HPRD | 12297500 |
OPRD1 | OPRD | opioid receptor, delta 1 | - | HPRD,BioGRID | 11278447 |
PPP3CA | CALN | CALNA | CALNA1 | CCN1 | CNA1 | PPP2B | protein phosphatase 3 (formerly 2B), catalytic subunit, alpha isoform | Co-fractionation | BioGRID | 9880537 |
SLC9A3R1 | EBP50 | NHERF | NHERF1 | NPHLOP2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | - | HPRD,BioGRID | 9560162 |9671706 |
SLC9A3R1 | EBP50 | NHERF | NHERF1 | NPHLOP2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | PDZ domain of NHERF binds to the C-terminus of B2AR. | BIND | 9560162 |9671706 |12621035 |
SLC9A3R2 | E3KARP | MGC104639 | NHE3RF2 | NHERF-2 | NHERF2 | OCTS2 | SIP-1 | SIP1 | TKA-1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 | PDZ1 domain of NHERF-2 interacts with the C-terminal tail of beta2-AR. | BIND | 9671706 |
SLC9A3R2 | E3KARP | MGC104639 | NHE3RF2 | NHERF-2 | NHERF2 | OCTS2 | SIP-1 | SIP1 | TKA-1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 | - | HPRD,BioGRID | 9671706 |
SRC | ASV | SRC1 | c-SRC | p60-Src | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | Affinity Capture-Western | BioGRID | 11013230 |
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
KEGG CALCIUM SIGNALING PATHWAY | 178 | 134 | All SZGR 2.0 genes in this pathway |
KEGG NEUROACTIVE LIGAND RECEPTOR INTERACTION | 272 | 195 | All SZGR 2.0 genes in this pathway |
KEGG ENDOCYTOSIS | 183 | 132 | All SZGR 2.0 genes in this pathway |
BIOCARTA GCR PATHWAY | 22 | 17 | All SZGR 2.0 genes in this pathway |
BIOCARTA CFTR PATHWAY | 12 | 11 | All SZGR 2.0 genes in this pathway |
BIOCARTA PLCE PATHWAY | 12 | 10 | All SZGR 2.0 genes in this pathway |
PID ARF6 TRAFFICKING PATHWAY | 49 | 34 | All SZGR 2.0 genes in this pathway |
PID ARF6 PATHWAY | 35 | 27 | All SZGR 2.0 genes in this pathway |
REACTOME SIGNALING BY GPCR | 920 | 449 | All SZGR 2.0 genes in this pathway |
REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | 305 | 177 | All SZGR 2.0 genes in this pathway |
REACTOME AMINE LIGAND BINDING RECEPTORS | 38 | 33 | All SZGR 2.0 genes in this pathway |
REACTOME GPCR DOWNSTREAM SIGNALING | 805 | 368 | All SZGR 2.0 genes in this pathway |
REACTOME G ALPHA S SIGNALLING EVENTS | 121 | 82 | All SZGR 2.0 genes in this pathway |
REACTOME GPCR LIGAND BINDING | 408 | 246 | All SZGR 2.0 genes in this pathway |
ONKEN UVEAL MELANOMA DN | 526 | 357 | All SZGR 2.0 genes in this pathway |
DEURIG T CELL PROLYMPHOCYTIC LEUKEMIA DN | 320 | 184 | All SZGR 2.0 genes in this pathway |
LIU TARGETS OF VMYB VS CMYB DN | 43 | 30 | All SZGR 2.0 genes in this pathway |
CHARAFE BREAST CANCER LUMINAL VS BASAL DN | 455 | 304 | All SZGR 2.0 genes in this pathway |
BASAKI YBX1 TARGETS UP | 290 | 177 | All SZGR 2.0 genes in this pathway |
VECCHI GASTRIC CANCER EARLY DN | 367 | 220 | All SZGR 2.0 genes in this pathway |
MULLIGHAN MLL SIGNATURE 1 UP | 380 | 236 | All SZGR 2.0 genes in this pathway |
MULLIGHAN MLL SIGNATURE 2 UP | 418 | 263 | All SZGR 2.0 genes in this pathway |
ENK UV RESPONSE KERATINOCYTE DN | 485 | 334 | All SZGR 2.0 genes in this pathway |
CHIARADONNA NEOPLASTIC TRANSFORMATION CDC25 DN | 153 | 100 | All SZGR 2.0 genes in this pathway |
GRAESSMANN APOPTOSIS BY DOXORUBICIN UP | 1142 | 669 | All SZGR 2.0 genes in this pathway |
GRAESSMANN RESPONSE TO MC AND DOXORUBICIN UP | 612 | 367 | All SZGR 2.0 genes in this pathway |
PEREZ TP53 TARGETS | 1174 | 695 | All SZGR 2.0 genes in this pathway |
RASHI RESPONSE TO IONIZING RADIATION 1 | 45 | 27 | All SZGR 2.0 genes in this pathway |
SIMBULAN UV RESPONSE NORMAL DN | 33 | 27 | All SZGR 2.0 genes in this pathway |
NUYTTEN EZH2 TARGETS UP | 1037 | 673 | All SZGR 2.0 genes in this pathway |
BUYTAERT PHOTODYNAMIC THERAPY STRESS DN | 637 | 377 | All SZGR 2.0 genes in this pathway |
KOYAMA SEMA3B TARGETS UP | 292 | 168 | All SZGR 2.0 genes in this pathway |
AMIT SERUM RESPONSE 240 MCF10A | 57 | 36 | All SZGR 2.0 genes in this pathway |
MORI MATURE B LYMPHOCYTE UP | 90 | 62 | All SZGR 2.0 genes in this pathway |
ONDER CDH1 TARGETS 2 DN | 464 | 276 | All SZGR 2.0 genes in this pathway |
ONDER CDH1 SIGNALING VIA CTNNB1 | 83 | 58 | All SZGR 2.0 genes in this pathway |
HOEGERKORP CD44 TARGETS DIRECT UP | 27 | 21 | All SZGR 2.0 genes in this pathway |
DAZARD RESPONSE TO UV NHEK DN | 318 | 220 | All SZGR 2.0 genes in this pathway |
BILD HRAS ONCOGENIC SIGNATURE | 261 | 166 | All SZGR 2.0 genes in this pathway |
KRIGE RESPONSE TO TOSEDOSTAT 6HR DN | 911 | 527 | All SZGR 2.0 genes in this pathway |
KRIGE RESPONSE TO TOSEDOSTAT 24HR DN | 1011 | 592 | All SZGR 2.0 genes in this pathway |
HELLER SILENCED BY METHYLATION DN | 105 | 67 | All SZGR 2.0 genes in this pathway |
SAGIV CD24 TARGETS DN | 46 | 26 | All SZGR 2.0 genes in this pathway |
BOQUEST STEM CELL DN | 216 | 143 | All SZGR 2.0 genes in this pathway |
YOSHIMURA MAPK8 TARGETS UP | 1305 | 895 | All SZGR 2.0 genes in this pathway |
SWEET LUNG CANCER KRAS DN | 435 | 289 | All SZGR 2.0 genes in this pathway |
MEISSNER BRAIN HCP WITH H3K4ME3 AND H3K27ME3 | 1069 | 729 | All SZGR 2.0 genes in this pathway |
MILI PSEUDOPODIA CHEMOTAXIS DN | 457 | 302 | All SZGR 2.0 genes in this pathway |
MILI PSEUDOPODIA HAPTOTAXIS DN | 668 | 419 | All SZGR 2.0 genes in this pathway |
CHIANG LIVER CANCER SUBCLASS CTNNB1 UP | 176 | 110 | All SZGR 2.0 genes in this pathway |
CHIANG LIVER CANCER SUBCLASS PROLIFERATION DN | 179 | 97 | All SZGR 2.0 genes in this pathway |
MEISSNER NPC HCP WITH H3K4ME2 | 491 | 319 | All SZGR 2.0 genes in this pathway |
WONG ADULT TISSUE STEM MODULE | 721 | 492 | All SZGR 2.0 genes in this pathway |
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 0 | 76 | 54 | All SZGR 2.0 genes in this pathway |
BRUINS UVC RESPONSE VIA TP53 GROUP B | 549 | 316 | All SZGR 2.0 genes in this pathway |
BRUINS UVC RESPONSE LATE | 1137 | 655 | All SZGR 2.0 genes in this pathway |
WINZEN DEGRADED VIA KHSRP | 100 | 70 | All SZGR 2.0 genes in this pathway |
ZWANG CLASS 1 TRANSIENTLY INDUCED BY EGF | 516 | 308 | All SZGR 2.0 genes in this pathway |
Section VI. microRNA annotation
miRNA family | Target position | miRNA ID | miRNA seq | ||
---|---|---|---|---|---|
UTR start | UTR end | Match method | |||
let-7/98 | 300 | 307 | 1A,m8 | hsa-let-7abrain | UGAGGUAGUAGGUUGUAUAGUU |
hsa-let-7bbrain | UGAGGUAGUAGGUUGUGUGGUU | ||||
hsa-let-7cbrain | UGAGGUAGUAGGUUGUAUGGUU | ||||
hsa-let-7dbrain | AGAGGUAGUAGGUUGCAUAGU | ||||
hsa-let-7ebrain | UGAGGUAGGAGGUUGUAUAGU | ||||
hsa-let-7fbrain | UGAGGUAGUAGAUUGUAUAGUU | ||||
hsa-miR-98brain | UGAGGUAGUAAGUUGUAUUGUU | ||||
hsa-let-7gSZ | UGAGGUAGUAGUUUGUACAGU | ||||
hsa-let-7ibrain | UGAGGUAGUAGUUUGUGCUGU | ||||
miR-15/16/195/424/497 | 334 | 340 | m8 | hsa-miR-15abrain | UAGCAGCACAUAAUGGUUUGUG |
hsa-miR-16brain | UAGCAGCACGUAAAUAUUGGCG | ||||
hsa-miR-15bbrain | UAGCAGCACAUCAUGGUUUACA | ||||
hsa-miR-195SZ | UAGCAGCACAGAAAUAUUGGC | ||||
hsa-miR-424 | CAGCAGCAAUUCAUGUUUUGAA | ||||
hsa-miR-497 | CAGCAGCACACUGUGGUUUGU | ||||
miR-200bc/429 | 315 | 321 | 1A | hsa-miR-200b | UAAUACUGCCUGGUAAUGAUGAC |
hsa-miR-200c | UAAUACUGCCGGGUAAUGAUGG | ||||
hsa-miR-429 | UAAUACUGUCUGGUAAAACCGU | ||||
miR-30-5p | 522 | 528 | 1A | hsa-miR-30a-5p | UGUAAACAUCCUCGACUGGAAG |
hsa-miR-30cbrain | UGUAAACAUCCUACACUCUCAGC | ||||
hsa-miR-30dSZ | UGUAAACAUCCCCGACUGGAAG | ||||
hsa-miR-30bSZ | UGUAAACAUCCUACACUCAGCU | ||||
hsa-miR-30e-5p | UGUAAACAUCCUUGACUGGA | ||||
miR-381 | 96 | 102 | 1A | hsa-miR-381 | UAUACAAGGGCAAGCUCUCUGU |
- SZ: miRNAs which differentially expressed in brain cortex of schizophrenia patients comparing with control samples using microarray. Click here to see the list of SZ related miRNAs.
- Brain: miRNAs which are expressed in brain based on miRNA microarray expression studies. Click here to see the list of brain related miRNAs.